BX Swiss TOP 30 CHF
1.268,49
PKT
+7,50
PKT
+0,59
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
05.05.05 | Swisscom Underweight | Lehman Brothers | |
05.05.05 | UBS Kaufen | Hamburger Sparkasse | |
04.05.05 | Roche Buy | Helvea | |
03.05.05 | Holcim Overweight | JP Morgan | |
03.05.05 | UBS Buy | Dresdner Kleinwort Wasserstein | |
04.05.05 | UBS Verkaufen | Helaba Trust | |
03.05.05 | UBS Buy | Sarasin Research | |
03.05.05 | UBS Strong Buy | SEB | |
04.05.05 | UBS Buy | Helvea | |
09.05.05 | UBS Kaufen | NATIONAL-BANK | |
02.05.05 | Lonza Reduce | Sarasin Research | |
03.05.05 | Holcim Accumulate | Helvea | |
03.05.05 | Sika Neutral | Helvea | |
03.05.05 | Lonza Buy | Helvea | |
02.05.05 | Holcim Neutral | Sarasin Research | |
02.05.05 | Nestlé Overweight | Lehman Brothers | |
02.05.05 | Adecco SA Accumulate | Helvea | |
02.05.05 | Sika Neutral | Sarasin Research | |
29.04.05 | Holcim Neutral | Sarasin Research | |
28.04.05 | ABB (Asea Brown Boveri) Buy | Sarasin Research | |
29.04.05 | ABB (Asea Brown Boveri) Kaufen | Helaba Trust | |
29.04.05 | ABB (Asea Brown Boveri) Kaufen | NATIONAL-BANK | |
27.04.05 | Roche Overweight | JP Morgan | |
29.04.05 | Novartis Sector Perform | Vontobel | |
27.04.05 | Richemont Outperform | Goldman Sachs | |
27.04.05 | Roche Outperform | Goldman Sachs | |
28.04.05 | UBS Buy | Sarasin Research | |
27.04.05 | Richemont Overweight | JP Morgan | |
29.04.05 | Roche Sector Outperform | Vontobel | |
28.04.05 | UBS Buy | Sarasin Research | |
27.04.05 | Richemont Verkaufen | Helaba Trust | |
26.04.05 | Nestlé Sector Outperform | Vontobel | |
27.04.05 | Roche Buy | Helvea | |
27.04.05 | Richemont Accumulate | Helvea | |
26.04.05 | Nestlé Overweight | JP Morgan | |
27.04.05 | Roche Kaufen | Hamburger Sparkasse | |
26.04.05 | Richemont Outperform | Goldman Sachs | |
26.04.05 | Nestlé Akkumulieren | Independent Research | |
26.04.05 | Geberit Market Outperform | Vontobel | |
26.04.05 | Richemont Buy | Sarasin Research |